Please assess the completion status of the following clinical trial:

Trial Title: Misoprostol Versus Uterine Striating by Bladder Filling for Pain Relief During Office Hysteroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Menopausal patients who have an indication for office hysteroscopy~Exclusion Criteria:~* Nulliparous patients, patients with cervical pathology and previous cesarean section or cervical surgery.

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Misoprostol (Type: ACTIVE_COMPARATOR): Misoprostol (400µg) is administered vaginally 12 hours before office hysteroscopy
- bladder Filling (Type: ACTIVE_COMPARATOR): Uterine straightening by bladder filling before office hysteroscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).